Today: 17 May 2026
Browse Category

NASDAQ:AVT 28 January 2026

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet shares jumped 11% to $58.65 by early afternoon Wednesday after quarterly earnings and a third-quarter forecast topped Wall Street estimates. The company reported fiscal Q2 sales of $6.319 billion and adjusted EPS of $1.05, beating analyst expectations. Arrow Electronics and TD SYNNEX also rose. Avnet projected Q3 sales of $6.20–$6.50 billion and adjusted EPS of $1.20–$1.30.
28 January 2026
··

Stock Market Today

  • Bipartisan Support for CLARITY Act Boosts Bitcoin and XRP in May
    May 16, 2026, 7:02 PM EDT. The CLARITY Act, which recently passed the Senate Banking Committee 15-9 with bipartisan support, sparked immediate gains in Bitcoin and XRP. Bitcoin surged to nearly $81,500, while XRP broke through $1.45 resistance briefly hitting $1.50. Historically, Bitcoin prices have rallied following significant regulatory milestones, including ETF approvals and government reserves, reaching highs of $126,000. XRP's performance is notably sensitive to regulatory clarity, exemplified by gains after an SEC ruling and classification as a digital commodity. If the CLARITY Act continues its momentum toward a Senate floor vote, both cryptocurrencies could experience further price appreciation by month-end, though Bitcoin and XRP are expected to move at different paces.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop